Dow Down 1.40% Nasdaq Down 1.59%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.16 Down 0.13(5.68%) 4:15PM EDT
Prev Close:2.29
Open:2.31
Bid:N/A
Ask:2.77 x 500
1y Target Est:7.00
Beta:3.29
Next Earnings Date:N/A
Day's Range:2.15 - 2.31
52wk Range:1.55 - 6.87
Volume:793,321
Avg Vol (3m):951,089
Market Cap:180.94M
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRADown 5.68%180.94M
DVAXDown 0.70%373.29M
PFEDown 1.42%184.84B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3,688.97
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.45
Quarterly EPS Est (Sep-14) :-0.11
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback